Cite
T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.
MLA
Titanji, Kehmia, et al. “T-Cell Receptor Activator of Nuclear Factor-ΚB Ligand/Osteoprotegerin Imbalance Is Associated with HIV-Induced Bone Loss in Patients with Higher CD4+ T-Cell Counts.” AIDS (London, England), vol. 32, no. 7, Apr. 2018, pp. 885–94. EBSCOhost, https://doi.org/10.1097/QAD.0000000000001764.
APA
Titanji, K., Vunnava, A., Foster, A., Sheth, A. N., Lennox, J. L., Knezevic, A., Shenvi, N., Easley, K. A., Ofotokun, I., & Weitzmann, M. N. (2018). T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts. AIDS (London, England), 32(7), 885–894. https://doi.org/10.1097/QAD.0000000000001764
Chicago
Titanji, Kehmia, Aswani Vunnava, Antonina Foster, Anandi N Sheth, Jeffrey L Lennox, Andrea Knezevic, Neeta Shenvi, Kirk A Easley, Ighovwerha Ofotokun, and M Neale Weitzmann. 2018. “T-Cell Receptor Activator of Nuclear Factor-ΚB Ligand/Osteoprotegerin Imbalance Is Associated with HIV-Induced Bone Loss in Patients with Higher CD4+ T-Cell Counts.” AIDS (London, England) 32 (7): 885–94. doi:10.1097/QAD.0000000000001764.